This information was published on 2025-11-03T16:12:39 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2597281 (IR 1881981) |
| (220) |
23 Sep 2025
|
| (300) |
US, 28 Mar 2025, 99108858
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment and prevention of lymphopenia; pharmaceutical preparations for use in stimulating lymphocyte production; pharmaceutical preparations for maintenance of lymphocyte counts; pharmaceutical preparations for the treatment and prevention of immunosuppressive side effects of chemotherapy, radiotherapy, and pathogenic infections. |
| (540) | COVIGEN |
| (550) | Word |
| (730) |
ImmunityBio, Inc.
|
Find out more about publications on the About page.